Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00920946 · ClinicalTrials.gov registry record · Phase 3

A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease

A Phase 3 study of Huntington Disease, sponsored by Medivation.

Completed
Registry status
Phase 3
Development phase
403
Enrollment target
20
Study locations

NCT00920946 is a Phase 3 study of Huntington Disease that has completed, run by Medivation. The registered enrollment target is 403 participants, below the 624-participant average among 35 other Huntington Disease trials with a reported enrollment target (35% lower). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00920946, a Phase 3 study of Huntington Disease, has completed, sponsored by Medivation.

COMPLETED
Registry status
Phase 3
Development phase
403 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to determine if Dimebon is safe and effective for the treatment of cognitive impairment in Huntington disease.

Conditions Studied

Huntington Disease

Interventions

  • OTHER Placebo
  • DRUG Dimebon

Study Locations (20)

California

  • - Davis
  • - Irvine
  • - La Jolla
  • - San Francisco

Florida

  • - Gainsville
  • - Miami

Kansas

  • - Kansas City
  • - Wichita

New York

  • - New York
  • - Rochester

North Carolina

  • - Durham
  • - Winstom-Salem

Ohio

  • - Cleveland
  • - Columbus

Arizona

  • - Scottsdale

Idaho

  • - Boise

Trial Details

FieldValue
Enrollment Target 403 participants
Start Date 2009-07
Phase Phase 3

Sponsor

Medivation

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00920946

The ClinicalTrials.gov registry entry for NCT00920946 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 403 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 624-participant average among 35 other Huntington Disease trials with a reported enrollment target (35% lower). The listed sponsor is Medivation, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Huntington Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00920946 reports 20 study locations spanning 12 distinct geographic areas - top geographies include California, Florida, Kansas.

Frequently Asked Questions

What is clinical trial NCT00920946 about?

NCT00920946 is a clinical study titled "A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease". The purpose of this study is to determine if Dimebon is safe and effective for the treatment of cognitive impairment in Huntington disease.

What is the current status of trial NCT00920946?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 403 participants. The study started on 2009-07.

What conditions does trial NCT00920946 study?

This clinical trial studies the following conditions: Huntington Disease.

What interventions are being tested in trial NCT00920946?

The interventions under investigation include: Placebo (OTHER), Dimebon (DRUG).

Who is sponsoring clinical trial NCT00920946?

This trial is sponsored by Medivation, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00920946 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Idaho, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Huntington Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Huntington Disease

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.